[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__Mitigation_1555 

# __Use of specific medicines__

## This Mitigation is enabled by the following technologies

* [antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3919.md)
* [antimalarial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3918.md)
* [anti-bacterial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3917.md)
* [corticosteroids](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3921.md)
* [protease inhibitors](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3920.md)

## Closest similar item

* [Therapeutic Drugs](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_763.md)
* [Medication prevention](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1469.md)
* [Non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_237.md)
* [Drug Therapies](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_228.md)
* [Medication delivery through blockchain](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_2118.md)
* [Drug modelling](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_57.md)
* [Non-Pharmaceutical Interventions (NPIs)](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_2419.md)
* [Monitoring of Pharmaceuticals and Metabolites](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1924.md)
* [Preventive and therapeutic measures](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1627.md)
* [Precision Medicine](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_762.md)

## Risks possibly mitigated by this Mitigation


## Property: has_MitigationPrinciple

Repurposing existing medicines such as anti-bacterial, antimalarial, and antiviral drugs, as well as protease inhibitors and corticosteroids, for the treatment of COVID-19. These medicines are used to reduce the severity of symptoms and prevent complications in infected individuals.

## Property: has_MitigationSource

* [Nurture to nature via COVID-19, a self-regenerating environmental strategy of environment in global context](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_44.md)

